$VXRT
Vaxart, Inc.

2022 Q3 Form 10-Q Financial Statement

#000143774922019415 Filed on August 08, 2022

View on sec.gov

Income Statement

Concept 2022 Q3 2022 Q2 2022 Q1
Revenue $0.00 $0.00 $85.00K
YoY Change -100.0% -100.0% -83.2%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $6.960M $9.321M $6.658M
YoY Change 38.04% 80.99% 12.09%
% of Gross Profit
Research & Development $22.47M $19.93M $18.20M
YoY Change 81.05% 85.58% 80.71%
% of Gross Profit
Depreciation & Amortization $489.0K $447.0K $370.0K
YoY Change 131.75% 272.5% 393.33%
% of Gross Profit
Operating Expenses $29.43M $29.25M $24.86M
YoY Change 68.62% 84.09% 55.22%
Operating Profit -$29.43M -$29.25M -$24.78M
YoY Change 70.58% 85.4% 59.73%
Interest Expense $458.0K $157.0K $35.00K
YoY Change 1661.54% 582.61% 288.89%
% of Operating Profit
Other Income/Expense, Net -$325.0K -$323.0K -$340.0K
YoY Change -3.56% -3.29% -27.66%
Pretax Income -$29.29M -$29.42M -$25.08M
YoY Change 66.8% 82.86% 57.06%
Income Tax $16.00K $15.00K $20.00K
% Of Pretax Income
Net Earnings -$29.31M -$29.43M -$25.10M
YoY Change 66.69% 82.61% 56.81%
Net Earnings / Revenue -29530.59%
Basic Earnings Per Share -$0.23 -$0.23 -$0.20
Diluted Earnings Per Share -$231.0K -$232.8K -$199.5K
COMMON SHARES
Basic Shares Outstanding 126.5M 126.4M 125.8M
Diluted Shares Outstanding

Balance Sheet

Concept 2022 Q3 2022 Q2 2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $114.8M $129.5M $147.7M
YoY Change -38.85% -29.82% -13.5%
Cash & Equivalents $50.77M $91.47M $123.4M
Short-Term Investments $64.00M $38.08M $24.25M
Other Short-Term Assets $5.613M $8.264M $6.441M
YoY Change 26.39% 72.13% 61.03%
Inventory
Prepaid Expenses
Receivables $0.00 $0.00 $81.00K
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $120.4M $137.8M $154.2M
YoY Change -37.4% -27.27% -12.11%
LONG-TERM ASSETS
Property, Plant & Equipment $12.28M $9.336M $7.629M
YoY Change 126.28% 115.16% 239.82%
Goodwill $4.508M $4.500M $4.500M
YoY Change
Intangibles $9.611M $9.949M $10.29M
YoY Change -31.65% -31.36% -31.1%
Long-Term Investments $0.00 $1.940M $9.349M
YoY Change -100.0% -86.47% 41.65%
Other Assets $1.923M $5.478M $1.556M
YoY Change 132.25% 1376.55% 321.68%
Total Long-Term Assets $54.93M $43.64M $46.20M
YoY Change 12.48% 10.91% 51.74%
TOTAL ASSETS
Total Short-Term Assets $120.4M $137.8M $154.2M
Total Long-Term Assets $54.93M $43.64M $46.20M
Total Assets $175.3M $181.5M $200.4M
YoY Change -27.3% -20.71% -2.67%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $7.916M $5.007M $4.017M
YoY Change 111.38% 35.25% -13.39%
Accrued Expenses $10.34M $8.440M $5.103M
YoY Change 135.79% 104.01% 60.67%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $1.300M $1.400M $800.0K
YoY Change -58.06% -56.25% -55.56%
Total Short-Term Liabilities $21.74M $15.93M $11.04M
YoY Change 72.61% 24.62% -5.21%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $216.0K $201.0K $186.0K
YoY Change 38.46% 41.55% 52.46%
Total Long-Term Liabilities $216.0K $201.0K $186.0K
YoY Change 38.46% 41.55% 52.46%
TOTAL LIABILITIES
Total Short-Term Liabilities $21.74M $15.93M $11.04M
Total Long-Term Liabilities $216.0K $201.0K $186.0K
Total Liabilities $53.00M $38.36M $34.01M
YoY Change 46.46% 31.99% 14.79%
SHAREHOLDERS EQUITY
Retained Earnings -$303.2M -$273.9M -$244.5M
YoY Change 52.67% 51.31% 48.25%
Common Stock $426.0M $417.4M $411.1M
YoY Change 5.57% 9.61% 20.52%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $122.3M $143.1M $166.4M
YoY Change
Total Liabilities & Shareholders Equity $175.3M $181.5M $200.4M
YoY Change -27.3% -20.71% -2.67%

Cashflow Statement

Concept 2022 Q3 2022 Q2 2022 Q1
OPERATING ACTIVITIES
Net Income -$29.31M -$29.43M -$25.10M
YoY Change 66.69% 82.61% 56.81%
Depreciation, Depletion And Amortization $489.0K $447.0K $370.0K
YoY Change 131.75% 272.5% 393.33%
Cash From Operating Activities -$14.61M -$25.90M -$25.11M
YoY Change 2.44% 96.79% 51.36%
INVESTING ACTIVITIES
Capital Expenditures -$7.066M -$2.326M $1.346M
YoY Change 433.69% 5.82% 118.86%
Acquisitions
YoY Change
Other Investing Activities -$24.01M -$6.549M $5.078M
YoY Change 677.43% -52.37% -125.47%
Cash From Investing Activities -$31.07M -$8.875M $3.732M
YoY Change 604.28% -44.35% -118.15%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $992.0K
YoY Change -98.49%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 4.988M 2.838M $1.040M
YoY Change -75.84% -92.34% -98.46%
NET CHANGE
Cash From Operating Activities -14.61M -25.90M -$25.11M
Cash From Investing Activities -31.07M -8.875M $3.732M
Cash From Financing Activities 4.988M 2.838M $1.040M
Net Change In Cash -40.70M -31.94M -$20.34M
YoY Change -2171.25% -501.41% -166.82%
FREE CASH FLOW
Cash From Operating Activities -$14.61M -$25.90M -$25.11M
Capital Expenditures -$7.066M -$2.326M $1.346M
Free Cash Flow -$7.549M -$23.57M -$26.46M
YoY Change -41.68% 115.02% 53.77%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
19926000 usd
CY2021Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
10737000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
38129000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
20810000 usd
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2022Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
9321000 usd
CY2021Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5150000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
15979000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
11094000 usd
CY2022Q2 us-gaap Operating Expenses
OperatingExpenses
29247000 usd
CY2021Q2 us-gaap Operating Expenses
OperatingExpenses
15887000 usd
us-gaap Operating Expenses
OperatingExpenses
54108000 usd
us-gaap Operating Expenses
OperatingExpenses
31904000 usd
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-29247000 usd
CY2021Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-15775000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-54023000 usd
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2022Q2 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
0 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-31286000 usd
CY2022Q2 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
157000 usd
CY2021Q2 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
23000 usd
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
192000 usd
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
32000 usd
CY2022Q2 vxrt Noncash Interest Expense On Liability
NoncashInterestExpenseOnLiability
323000 usd
CY2021Q2 vxrt Noncash Interest Expense On Liability
NoncashInterestExpenseOnLiability
334000 usd
vxrt Noncash Interest Expense On Liability
NoncashInterestExpenseOnLiability
663000 usd
vxrt Noncash Interest Expense On Liability
NoncashInterestExpenseOnLiability
800000 usd
CY2022Q2 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-2000 usd
CY2021Q2 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
0 usd
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-2000 usd
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-1000 usd
dei Amendment Flag
AmendmentFlag
false
CY2022Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-29415000 usd
CY2021Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-16086000 usd
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-54496000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-32055000 usd
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
15000 usd
CY2021Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
30000 usd
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
35000 usd
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
CY2022Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
68000 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-29430000 usd
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-16116000 usd
us-gaap Net Income Loss
NetIncomeLoss
-54531000 usd
us-gaap Net Income Loss
NetIncomeLoss
-32123000 usd
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.23
CY2021Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.13
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.43
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.27
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
126428298
CY2021Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
120925570
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
126111777
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
118174099
CY2022Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2022Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2022Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-29430000 usd
CY2022Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-16116000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
1147000 usd
us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
-335000 usd
us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
-9000 usd
CY2022Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
150000000
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
150000000
CY2022Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-29530000 usd
CY2021Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-16120000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-54866000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-32132000 usd
CY2022Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
126446036
CY2022Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
126446036
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
166365000 usd
CY2022Q2 vxrt Stock Issued During Period Value Exercise Of Common Stock Warrants
StockIssuedDuringPeriodValueExerciseOfCommonStockWarrants
2000 usd
CY2022Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
31000 usd
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
125594393
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
3421000 usd
CY2022Q2 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-100000 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-29430000 usd
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
125594393
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
143094000 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
187531000 usd
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
3797000 usd
vxrt Stock Issued During Period Value Exercise Of Common Stock Warrants
StockIssuedDuringPeriodValueExerciseOfCommonStockWarrants
2000 usd
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
79000 usd
us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
422000 usd
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
6551000 usd
us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-335000 usd
CY2021Q2 us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
1824000 usd
us-gaap Net Income Loss
NetIncomeLoss
-54531000 usd
us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
5006000 usd
CY2021Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
0 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
143094000 usd
us-gaap Tangible Asset Impairment Charges
TangibleAssetImpairmentCharges
0 usd
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
176235000 usd
CY2021Q4 us-gaap Goodwill
Goodwill
4500000 usd
us-gaap Operating Lease Payments
OperatingLeasePayments
1800000 usd
CY2021Q2 us-gaap Dilutive Securities
DilutiveSecurities
0 usd
CY2021Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
36202000 usd
us-gaap Dilutive Securities
DilutiveSecurities
0 usd
us-gaap Dilutive Securities
DilutiveSecurities
0 usd
CY2021Q2 vxrt Stock Issued During Period Value Exercise Of Common Stock Warrants
StockIssuedDuringPeriodValueExerciseOfCommonStockWarrants
200000 usd
CY2021Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
661000 usd
CY2021Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2604000 usd
CY2021Q2 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-4000 usd
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2022-06-30
dei Document Transition Report
DocumentTransitionReport
false
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-16116000 usd
dei Entity File Number
EntityFileNumber
001-35285
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
199782000 usd
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
123404000 usd
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
101914000 usd
vxrt Stock Issued During Period Value Exercise Of Common Stock Warrants
StockIssuedDuringPeriodValueExerciseOfCommonStockWarrants
1849000 usd
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
892000 usd
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
59-1212264
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
3855000 usd
us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-9000 usd
dei Entity Address Address Line1
EntityAddressAddressLine1
170 Harbor Way, Suite 300
us-gaap Net Income Loss
NetIncomeLoss
-32123000 usd
dei Entity Address City Or Town
EntityAddressCityOrTown
South San Francisco
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
199782000 usd
us-gaap Net Income Loss
NetIncomeLoss
-54531000 usd
us-gaap Net Income Loss
NetIncomeLoss
-32123000 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
2352000 usd
dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
us-gaap Depreciation And Amortization
DepreciationAndAmortization
1989000 usd
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
94080
us-gaap Investment Income Amortization Of Premium
InvestmentIncomeAmortizationOfPremium
70000 usd
us-gaap Investment Income Amortization Of Premium
InvestmentIncomeAmortizationOfPremium
24000 usd
dei City Area Code
CityAreaCode
650
dei Local Phone Number
LocalPhoneNumber
550-3500
dei Security12b Title
Security12bTitle
Common stock, $0.0001 par value
us-gaap Share Based Compensation
ShareBasedCompensation
6551000 usd
dei Trading Symbol
TradingSymbol
VXRT
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2022Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
126506309
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
91468000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
143745000 usd
CY2022Q2 us-gaap Short Term Investments
ShortTermInvestments
38078000 usd
CY2021Q4 us-gaap Short Term Investments
ShortTermInvestments
22742000 usd
CY2022Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
0 usd
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
71000 usd
CY2022Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
8264000 usd
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2609000 usd
CY2022Q2 us-gaap Assets Current
AssetsCurrent
137810000 usd
CY2021Q4 us-gaap Assets Current
AssetsCurrent
169167000 usd
CY2022Q2 us-gaap Long Term Investments
LongTermInvestments
1940000 usd
CY2021Q4 us-gaap Long Term Investments
LongTermInvestments
16210000 usd
CY2022Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
9336000 usd
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
6601000 usd
CY2022Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
12433000 usd
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
13168000 usd
CY2022Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
9949000 usd
CY2021Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
10624000 usd
CY2022Q2 us-gaap Goodwill
Goodwill
4508000 usd
CY2021Q4 us-gaap Goodwill
Goodwill
4508000 usd
CY2022Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
5478000 usd
CY2021Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
890000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
3855000 usd
vxrt Noncash Interest Expense On Liability
NoncashInterestExpenseOnLiability
663000 usd
CY2022Q2 us-gaap Assets
Assets
181454000 usd
vxrt Noncash Interest Expense On Liability
NoncashInterestExpenseOnLiability
800000 usd
CY2021Q4 us-gaap Assets
Assets
221168000 usd
CY2022Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
5007000 usd
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
3872000 usd
CY2022Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1110000 usd
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1011000 usd
CY2022Q2 vxrt Liability Related To Sale Of Future Royalties Current
LiabilityRelatedToSaleOfFutureRoyaltiesCurrent
1369000 usd
CY2021Q4 vxrt Liability Related To Sale Of Future Royalties Current
LiabilityRelatedToSaleOfFutureRoyaltiesCurrent
836000 usd
vxrt Noncash Revenue Related To Sale Of Future Royalties
NoncashRevenueRelatedToSaleOfFutureRoyalties
152000 usd
CY2022Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
8440000 usd
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
5064000 usd
CY2022Q2 us-gaap Liabilities Current
LiabilitiesCurrent
15926000 usd
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
10783000 usd
CY2022Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
11569000 usd
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
11997000 usd
CY2022Q2 vxrt Liability Related To Sale Of Future Royalties Noncurrent
LiabilityRelatedToSaleOfFutureRoyaltiesNoncurrent
10664000 usd
CY2021Q4 vxrt Liability Related To Sale Of Future Royalties Noncurrent
LiabilityRelatedToSaleOfFutureRoyaltiesNoncurrent
10686000 usd
CY2022Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
201000 usd
CY2021Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
171000 usd
CY2022Q2 us-gaap Liabilities
Liabilities
38360000 usd
CY2021Q4 us-gaap Liabilities
Liabilities
33637000 usd
CY2022Q2 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
vxrt Noncash Revenue Related To Sale Of Future Royalties
NoncashRevenueRelatedToSaleOfFutureRoyalties
802000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-71000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-227000 usd
CY2021Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2022Q2 us-gaap Common Stock Value
CommonStockValue
13000 usd
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
13000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
10243000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
3473000 usd
CY2022Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
417372000 usd
CY2021Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
406943000 usd
CY2022Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-273882000 usd
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-219351000 usd
CY2022Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-409000 usd
CY2021Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-74000 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
143094000 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
187531000 usd
CY2022Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
181454000 usd
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
221168000 usd
CY2021Q2 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
112000 usd
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
85000 usd
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
618000 usd
us-gaap Net Income Loss
NetIncomeLoss
-54531000 usd
us-gaap Net Income Loss
NetIncomeLoss
-32123000 usd
CY2022Q2 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
-100000 usd
CY2021Q2 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
-4000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
1348000 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
3060000 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-1596000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-51012000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-29751000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
3672000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2818000 usd
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
17471000 usd
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
34890000 usd
us-gaap Proceeds From Maturities Prepayments And Calls Of Shortterm Investments
ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments
16000000 usd
us-gaap Proceeds From Maturities Prepayments And Calls Of Shortterm Investments
ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments
1200000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-5143000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-36508000 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
3797000 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
101914000 usd
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
2000 usd
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
1849000 usd
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
79000 usd
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
892000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
3878000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
104655000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-52277000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
38396000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
143745000 usd
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
126870000 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
91468000 usd
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
165266000 usd
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
125000 usd
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
56000 usd
vxrt Leaserelated Assets And Liabilities Derecognized On Early Termination And Modification Of Leases
LeaserelatedAssetsAndLiabilitiesDerecognizedOnEarlyTerminationAndModificationOfLeases
0 usd
vxrt Leaserelated Assets And Liabilities Derecognized On Early Termination And Modification Of Leases
LeaserelatedAssetsAndLiabilitiesDerecognizedOnEarlyTerminationAndModificationOfLeases
158000 usd
us-gaap Noncash Or Part Noncash Acquisition Value Of Assets Acquired1
NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1
333000 usd
us-gaap Noncash Or Part Noncash Acquisition Value Of Assets Acquired1
NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1
314000 usd
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
6601000 usd
CY2022Q2 us-gaap Depreciation
Depreciation
447000 usd
us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt;"><b>Use of Estimates</b> – The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses and disclosure of contingent assets and liabilities in the financial statements and accompanying notes. Actual results and outcomes could differ from these estimates and assumptions.</p> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt;"> </p>
CY2022Q2 us-gaap Investments And Cash
InvestmentsAndCash
131895000 usd
CY2022Q2 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
409000 usd
CY2022Q2 vxrt Investments And Cash Fair Value Disclosure
InvestmentsAndCashFairValueDisclosure
131486000 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
91468000 usd
CY2022Q2 us-gaap Short Term Investments
ShortTermInvestments
38078000 usd
CY2022Q2 us-gaap Long Term Investments
LongTermInvestments
1940000 usd
CY2021Q4 us-gaap Investments And Cash
InvestmentsAndCash
182771000 usd
CY2021Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
74000 usd
CY2021Q4 vxrt Investments And Cash Fair Value Disclosure
InvestmentsAndCashFairValueDisclosure
182697000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
143745000 usd
CY2021Q4 us-gaap Short Term Investments
ShortTermInvestments
22742000 usd
CY2021Q4 us-gaap Long Term Investments
LongTermInvestments
16210000 usd
CY2022Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
0 usd
CY2022Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
11458000 usd
CY2021Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
7906000 usd
CY2022Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
2122000 usd
CY2021Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
1305000 usd
CY2022Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
9336000 usd
CY2021Q2 us-gaap Depreciation
Depreciation
120000 usd
us-gaap Depreciation
Depreciation
817000 usd
us-gaap Depreciation
Depreciation
195000 usd
us-gaap Tangible Asset Impairment Charges
TangibleAssetImpairmentCharges
0 usd
CY2022Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
12400000 usd
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
13200000 usd
CY2022Q2 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
10680000 usd
CY2021Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
10680000 usd
CY2022Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
731000 usd
CY2021Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
56000 usd
CY2022Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
9949000 usd
CY2021Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
10624000 usd
CY2022Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
337000 usd
CY2021Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
433000 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
675000 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
866000 usd
CY2022Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
675000 usd
CY2022Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
1350000 usd
CY2022Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
1350000 usd
CY2022Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
1350000 usd
CY2022Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
1350000 usd
CY2022Q2 vxrt Finitelived Intangible Asset Expected Amortization After Year Four
FinitelivedIntangibleAssetExpectedAmortizationAfterYearFour
3874000 usd
CY2022Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
9949000 usd
CY2022Q2 us-gaap Goodwill
Goodwill
4500000 usd
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0 usd
CY2022Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
3200000 usd
CY2021Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
2786000 usd
CY2022Q2 vxrt Accrued Clinical And Manufacturing Expenses Current
AccruedClinicalAndManufacturingExpensesCurrent
913000 usd
CY2021Q4 vxrt Accrued Clinical And Manufacturing Expenses Current
AccruedClinicalAndManufacturingExpensesCurrent
986000 usd
CY2022Q2 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
907000 usd
CY2021Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
556000 usd
CY2022Q2 vxrt Accrued Litigation Settlement Current
AccruedLitigationSettlementCurrent
2000000 usd
CY2021Q4 vxrt Accrued Litigation Settlement Current
AccruedLitigationSettlementCurrent
0 usd
CY2022Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
1420000 usd
CY2021Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
736000 usd
CY2022Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
8440000 usd
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
5064000 usd
CY2022Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0927 pure
CY2022Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P6Y5M8D
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
1060000 usd
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
2168000 usd
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
2242000 usd
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
2316000 usd
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
2852000 usd
CY2022Q2 vxrt Lessee Operating Lease Liability To Be Paid After Year Four
LesseeOperatingLeaseLiabilityToBePaidAfterYearFour
6770000 usd
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
17408000 usd
CY2022Q2 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
4729000 usd
CY2022Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
12679000 usd
CY2022Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1110000 usd
CY2022Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
11569000 usd
CY2022Q2 vxrt Lessee Finance Lease Number Of Leases
LesseeFinanceLeaseNumberOfLeases
0 pure
CY2022Q2 us-gaap Short Term Lease Commitment Amount
ShortTermLeaseCommitmentAmount
0 usd
CY2022Q2 us-gaap Operating Lease Cost
OperatingLeaseCost
731000 usd
CY2021Q2 us-gaap Operating Lease Cost
OperatingLeaseCost
511000 usd
us-gaap Operating Lease Cost
OperatingLeaseCost
1450000 usd
us-gaap Operating Lease Cost
OperatingLeaseCost
1173000 usd
CY2022Q2 us-gaap Short Term Lease Cost
ShortTermLeaseCost
100000 usd
CY2021Q2 us-gaap Short Term Lease Cost
ShortTermLeaseCost
71000 usd
us-gaap Short Term Lease Cost
ShortTermLeaseCost
218000 usd
us-gaap Short Term Lease Cost
ShortTermLeaseCost
131000 usd
CY2022Q2 us-gaap Variable Lease Cost
VariableLeaseCost
264000 usd
CY2021Q2 us-gaap Variable Lease Cost
VariableLeaseCost
331000 usd
us-gaap Variable Lease Cost
VariableLeaseCost
529000 usd
us-gaap Variable Lease Cost
VariableLeaseCost
624000 usd
CY2022Q2 us-gaap Sublease Income
SubleaseIncome
-0 usd
CY2021Q2 us-gaap Sublease Income
SubleaseIncome
-0 usd
us-gaap Sublease Income
SubleaseIncome
-0 usd
us-gaap Sublease Income
SubleaseIncome
36000 usd
CY2022Q2 us-gaap Lease Cost
LeaseCost
1095000 usd
CY2021Q2 us-gaap Lease Cost
LeaseCost
913000 usd
us-gaap Lease Cost
LeaseCost
2197000 usd
us-gaap Lease Cost
LeaseCost
1892000 usd
CY2022Q2 us-gaap Operating Lease Payments
OperatingLeasePayments
933000 usd
CY2021Q2 us-gaap Operating Lease Payments
OperatingLeasePayments
886000 usd
us-gaap Operating Lease Payments
OperatingLeasePayments
1800000 usd
CY2022Q2 vxrt Accrued Litigation Settlement Current
AccruedLitigationSettlementCurrent
2000000.0 usd
CY2022Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2022Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2022Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
150000000
CY2022Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
150000000
us-gaap Dividends
Dividends
0 usd
CY2022Q2 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
15945390
CY2021Q4 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
16031282
CY2022Q2 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
227434
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
5582742
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
10216106
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
4.96
vxrt Share Based Compensation Arrangement By Share Based Payment Award Shares Available For Grant Decrease From Grants
ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesAvailableForGrantDecreaseFromGrants
5137646
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
4628585
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
4.49
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
70643
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
1.11
vxrt Share Based Compensation Arrangement By Share Based Payment Award Forfeited
ShareBasedCompensationArrangementByShareBasedPaymentAwardForfeited
430720
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
429196
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
6.72
vxrt Share Based Compensation Arrangement By Share Based Payment Award Canceled
ShareBasedCompensationArrangementByShareBasedPaymentAwardCanceled
28750
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
38934
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
10.44
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
904566
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
14305918
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
4.76
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
14305918
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
4.76
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P8Y7M20D
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
7000000.0 usd
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
4941521
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
3.33
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P7Y5M1D
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
5500000 usd
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
79000 usd
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
70643
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
225000 usd
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
892000 usd
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
571926
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
3200000 usd
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
3.98
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
6.23
CY2022Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
3421000 usd
CY2021Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2604000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
6551000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
3855000 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-29430000 usd
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-16116000 usd
us-gaap Net Income Loss
NetIncomeLoss
-54531000 usd
us-gaap Net Income Loss
NetIncomeLoss
-32123000 usd
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
126428298
CY2021Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
120925570
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
126111777
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
118174099
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.23
CY2021Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.13
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.43
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.27
CY2022Q2 us-gaap Dilutive Securities
DilutiveSecurities
0 usd
CY2022Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
14490693
CY2021Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
8123363
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
12818877
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
7973194

Files In Submission

Name View Source Status
0001437749-22-019415-index-headers.html Edgar Link pending
0001437749-22-019415-index.html Edgar Link pending
0001437749-22-019415.txt Edgar Link pending
0001437749-22-019415-xbrl.zip Edgar Link pending
ex_381323.htm Edgar Link pending
ex_381324.htm Edgar Link pending
ex_389860.htm Edgar Link pending
ex_404948.htm Edgar Link pending
ex_405687.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
pipeline2022q2.jpg Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
vxrt-20220630.xsd Edgar Link pending
vxrt20220630_10q.htm Edgar Link pending
vxrt-20220630_cal.xml Edgar Link unprocessable
vxrt-20220630_lab.xml Edgar Link unprocessable
vxrt20220630_10q_htm.xml Edgar Link completed
vxrt-20220630_def.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
vxrt-20220630_pre.xml Edgar Link unprocessable